CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Brigatinib

布格替尼 杂质对照品Brigatinib Impurities

91 个杂质条目91 impurity entries

本页汇总 布格替尼 的 91 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 91 impurity reference standards of Brigatinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 布格替尼(Brigatinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesInvestigation into the Formation of Impurities during the Optimization of Brigatinib
    ACS omega · 2020 · Guo A et al.  ·  PMID 33225157  ·  DOI
  2. 杂质研究Impurity studiesA drug-to-metabolite ratio-based quantitative analytical approach for evaluation of combination therapy through impact assessment of brigatinib on the pharmacokinetics of tazemetostat and its primary metabolite
    Drug metabolism and disposition: the biological fate of chemicals · 2026 · Rajput N et al.  ·  PMID 42070501  ·  DOI
  3. 分析方法Analytical MethodsDevelopment and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasma
    Biomedical chromatography : BMC · 2023 · Gulikers JL et al.  ·  PMID 36941218  ·  DOI
  4. 分析方法Analytical MethodsBioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates
    Journal of pharmaceutical and biomedical analysis · 2018 · Sparidans RW et al.  ·  PMID 30149189  ·  DOI
  5. 分析方法Analytical MethodsDevelopment and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasma
    Biomedical chromatography : BMC · 2024 · Hollander EM et al.  ·  PMID 39136165  ·  DOI

布格替尼 —— 原料药与杂质对照品Brigatinib — drug substance & impurities

共 92 个条目(含原料药本体)92 items incl. the drug substance
Brigatinib structure
原料药 APIAPI
布格替尼Brigatinib
Brigatinib
CAS No.1197953-54-0
Chemical FormulaC29H39ClN7O2P
Purity>95%询价On request
10mg25mg50mg100mg
Brigatinib Impurity 1 structure
1
布格替尼杂质1Brigatinib Impurity 1
Brigatinib Impurity 1
CAS No.1089279-90-2
Chemical FormulaC14H21N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Brigatinib Impurity 2 structure
2
布格替尼杂质2Brigatinib Impurity 2
Brigatinib Impurity 2
CAS No.53617-36-0
Chemical FormulaC10H21N3
Purity>95%询价On request
10mg25mg50mg100mg
Brigatinib Impurity 3 structure
3
布格替尼杂质3Brigatinib Impurity 3
Brigatinib Impurity 3
CAS No.1197953-49-3
Chemical FormulaC12H12Cl2N3OP
Purity>95%询价On request
10mg25mg50mg100mg
Brigatinib Impurity 4 structure
4
布格替尼杂质4Brigatinib Impurity 4
Brigatinib Impurity 4
CAS No.761440-75-9
Chemical FormulaC17H28N4O
Purity>95%询价On request
10mg25mg50mg100mg
Brigatinib Impurity 5 structure
5
布格替尼杂质5Brigatinib Impurity 5
Brigatinib Impurity 5
CAS No.1197958-12-5
Chemical FormulaC26H34ClN6O2P
Purity>95%询价On request
10mg25mg50mg100mg
Brigatinib Impurity 6 structure
6
布格替尼杂质6Brigatinib Impurity 6
Brigatinib Impurity 6
CAS No.1197958-75-0
Chemical FormulaC28H37ClN7O2P
Purity>95%询价On request
10mg25mg50mg100mg
8
布格替尼杂质8Brigatinib Impurity 8
Brigatinib Impurity 8
CAS No.1197958-95-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
9
布格替尼杂质9Brigatinib Impurity 9
Brigatinib Impurity 9
CAS No.1197960-18-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
10
布格替尼杂质10Brigatinib Impurity 10
Brigatinib Impurity 10
CAS No.1197958-82-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
11
布格替尼杂质11Brigatinib Impurity 11
Brigatinib Impurity 11
CAS No.2498545-21-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
12
布格替尼杂质12Brigatinib Impurity 12
Brigatinib Impurity 12
CAS No.1197958-35-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
13
布格替尼杂质13Brigatinib Impurity 13
Brigatinib Impurity 13
CAS No.1197958-20-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
14
布格替尼杂质14Brigatinib Impurity 14
Brigatinib Impurity 14
CAS No.1197958-98-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
15
布格替尼杂质15Brigatinib Impurity 15
Brigatinib Impurity 15
CAS No.1197958-17-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
16
布格替尼杂质16Brigatinib Impurity 16
Brigatinib Impurity 16
CAS No.1197964-45-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
17
布格替尼杂质17Brigatinib Impurity 17
Brigatinib Impurity 17
CAS No.1452345-06-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
18
布格替尼杂质18Brigatinib Impurity 18
Brigatinib Impurity 18
CAS No.1197961-02-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
19
布格替尼杂质19Brigatinib Impurity 19
Brigatinib Impurity 19
CAS No.1197960-74-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
20
布格替尼杂质20Brigatinib Impurity 20
Brigatinib Impurity 20
CAS No.1197960-56-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
21
布格替尼杂质21Brigatinib Impurity 21
Brigatinib Impurity 21
CAS No.1197959-38-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
22
布格替尼杂质22Brigatinib Impurity 22
Brigatinib Impurity 22
CAS No.1197962-75-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
23
布格替尼杂质23Brigatinib Impurity 23
Brigatinib Impurity 23
CAS No.1197959-79-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
24
布格替尼杂质24Brigatinib Impurity 24
Brigatinib Impurity 24
CAS No.1197959-24-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
25
布格替尼杂质25Brigatinib Impurity 25
Brigatinib Impurity 25
CAS No.1197958-44-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
26
布格替尼杂质26Brigatinib Impurity 26
Brigatinib Impurity 26
CAS No.2353496-92-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
27
布格替尼杂质27Brigatinib Impurity 27
Brigatinib Impurity 27
CAS No.1197960-89-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
28
布格替尼杂质28Brigatinib Impurity 28
Brigatinib Impurity 28
CAS No.1452343-98-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
29
布格替尼杂质29Brigatinib Impurity 29
Brigatinib Impurity 29
CAS No.1373211-89-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
30
布格替尼杂质30Brigatinib Impurity 30
Brigatinib Impurity 30
CAS No.1373211-92-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
31
布格替尼杂质31Brigatinib Impurity 31
Brigatinib Impurity 31
CAS No.2756979-42-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
32
布格替尼杂质32Brigatinib Impurity 32
Brigatinib Impurity 32
CAS No.2389120-46-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
33
布格替尼杂质33Brigatinib Impurity 33
Brigatinib Impurity 33
CAS No.3052785-52-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
34
布格替尼杂质34Brigatinib Impurity 34
Brigatinib Impurity 34
CAS No.2756978-81-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
35
布格替尼杂质35Brigatinib Impurity 35
Brigatinib Impurity 35
CAS No.1197960-98-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
36
布格替尼杂质36Brigatinib Impurity 36
Brigatinib Impurity 36
CAS No.1373212-07-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
37
布格替尼杂质37Brigatinib Impurity 37
Brigatinib Impurity 37
CAS No.2756979-13-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
38
布格替尼杂质38Brigatinib Impurity 38
Brigatinib Impurity 38
CAS No.1197961-84-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
39
布格替尼杂质39Brigatinib Impurity 39
Brigatinib Impurity 39
CAS No.1197960-72-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
40
布格替尼杂质40Brigatinib Impurity 40
Brigatinib Impurity 40
CAS No.1197964-58-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
41
布格替尼杂质41Brigatinib Impurity 41
Brigatinib Impurity 41
CAS No.1373212-13-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
42
布格替尼杂质42Brigatinib Impurity 42
Brigatinib Impurity 42
CAS No.1373211-98-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
43
布格替尼杂质43Brigatinib Impurity 43
Brigatinib Impurity 43
CAS No.3052785-10-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
44
布格替尼杂质44Brigatinib Impurity 44
Brigatinib Impurity 44
CAS No.2846061-68-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
45
布格替尼杂质45Brigatinib Impurity 45
Brigatinib Impurity 45
CAS No.2640178-34-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
46
布格替尼杂质46Brigatinib Impurity 46
Brigatinib Impurity 46
CAS No.1197959-85-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
47
布格替尼杂质47Brigatinib Impurity 47
Brigatinib Impurity 47
CAS No.1197958-92-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
48
布格替尼杂质48Brigatinib Impurity 48
Brigatinib Impurity 48
CAS No.2595158-18-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
49
布格替尼杂质49Brigatinib Impurity 49
Brigatinib Impurity 49
CAS No.2894838-25-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
50
布格替尼杂质50Brigatinib Impurity 50
Brigatinib Impurity 50
CAS No.2498545-20-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
51
布格替尼杂质51Brigatinib Impurity 51
Brigatinib Impurity 51
CAS No.1197964-40-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
52
布格替尼杂质52Brigatinib Impurity 52
Brigatinib Impurity 52
CAS No.2894838-27-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
53
布格替尼杂质53Brigatinib Impurity 53
Brigatinib Impurity 53
CAS No.2638536-18-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
54
布格替尼杂质54Brigatinib Impurity 54
Brigatinib Impurity 54
CAS No.2595158-30-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
55
布格替尼杂质55Brigatinib Impurity 55
Brigatinib Impurity 55
CAS No.1197959-06-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
56
布格替尼杂质56Brigatinib Impurity 56
Brigatinib Impurity 56
CAS No.1373212-02-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
57
布格替尼杂质57Brigatinib Impurity 57
Brigatinib Impurity 57
CAS No.2734728-20-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
58
布格替尼杂质58Brigatinib Impurity 58
Brigatinib Impurity 58
CAS No.2595158-59-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
59
布格替尼杂质59Brigatinib Impurity 59
Brigatinib Impurity 59
CAS No.1197962-49-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
60
布格替尼杂质60Brigatinib Impurity 60
Brigatinib Impurity 60
CAS No.2756979-41-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
61
布格替尼杂质61Brigatinib Impurity 61
Brigatinib Impurity 61
CAS No.1197960-31-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
62
布格替尼杂质62Brigatinib Impurity 62
Brigatinib Impurity 62
CAS No.2619511-65-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
63
布格替尼杂质63Brigatinib Impurity 63
Brigatinib Impurity 63
CAS No.3052785-56-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
64
布格替尼杂质64Brigatinib Impurity 64
Brigatinib Impurity 64
CAS No.1197958-40-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
65
布格替尼杂质65Brigatinib Impurity 65
Brigatinib Impurity 65
CAS No.2640178-37-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
66
布格替尼杂质66Brigatinib Impurity 66
Brigatinib Impurity 66
CAS No.2595158-57-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
67
布格替尼杂质67Brigatinib Impurity 67
Brigatinib Impurity 67
CAS No.2595158-42-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
68
布格替尼杂质68Brigatinib Impurity 68
Brigatinib Impurity 68
CAS No.1197959-14-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
69
布格替尼杂质69Brigatinib Impurity 69
Brigatinib Impurity 69
CAS No.2883565-87-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
70
布格替尼杂质70Brigatinib Impurity 70
Brigatinib Impurity 70
CAS No.1197958-61-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
71
布格替尼杂质71Brigatinib Impurity 71
Brigatinib Impurity 71
CAS No.1197959-40-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
72
布格替尼杂质72Brigatinib Impurity 72
Brigatinib Impurity 72
CAS No.1197953-88-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
73
布格替尼杂质73Brigatinib Impurity 73
Brigatinib Impurity 73
CAS No.2379226-98-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
74
布格替尼杂质74Brigatinib Impurity 74
Brigatinib Impurity 74
CAS No.1197962-84-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
75
布格替尼杂质75Brigatinib Impurity 75
Brigatinib Impurity 75
CAS No.2758531-85-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
76
布格替尼杂质76Brigatinib Impurity 76
Brigatinib Impurity 76
CAS No.1373211-90-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
77
布格替尼杂质77Brigatinib Impurity 77
Brigatinib Impurity 77
CAS No.2883568-24-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
78
布格替尼杂质78Brigatinib Impurity 78
Brigatinib Impurity 78
CAS No.1197959-00-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
79
布格替尼杂质79Brigatinib Impurity 79
Brigatinib Impurity 79
CAS No.2395899-56-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
80
布格替尼杂质80Brigatinib Impurity 80
Brigatinib Impurity 80
CAS No.2883567-43-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
81
布格替尼杂质81Brigatinib Impurity 81
Brigatinib Impurity 81
CAS No.2883567-31-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
82
布格替尼杂质82Brigatinib Impurity 82
Brigatinib Impurity 82
CAS No.2883559-27-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
83
布格替尼杂质83Brigatinib Impurity 83
Brigatinib Impurity 83
CAS No.1197960-45-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
84
布格替尼杂质84Brigatinib Impurity 84
Brigatinib Impurity 84
CAS No.2883567-24-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
85
布格替尼杂质85Brigatinib Impurity 85
Brigatinib Impurity 85
CAS No.2883566-10-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
86
布格替尼杂质86Brigatinib Impurity 86
Brigatinib Impurity 86
CAS No.2135615-93-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
87
布格替尼杂质87Brigatinib Impurity 87
Brigatinib Impurity 87
CAS No.1373212-14-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
88
布格替尼杂质88Brigatinib Impurity 88
Brigatinib Impurity 88
CAS No.2390554-36-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
89
布格替尼杂质89Brigatinib Impurity 89
Brigatinib Impurity 89
CAS No.2883566-95-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
90
布格替尼杂质90Brigatinib Impurity 90
Brigatinib Impurity 90
CAS No.2498545-28-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
91
布格替尼杂质91Brigatinib Impurity 91
Brigatinib Impurity 91
CAS No.1197960-52-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
92
布格替尼杂质92Brigatinib Impurity 92
Brigatinib Impurity 92
CAS No.2883566-59-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

布格替尼 —— 研究文献与合成路线Brigatinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 布格替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Brigatinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Metastasis-Related Oncoproteins and a Reshuffling Kinome Profile
    Ren C, Sun N, Liu H, et al. · Journal of medicinal chemistry · 2021 · 被引 32cited 32
  2. Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance
    Sun N, Ren C, Kong Y, et al. · European journal of medicinal chemistry · 2020 · 被引 66cited 66
  3. Investigation into the Formation of Impurities during the Optimization of Brigatinib
    Guo A, Zhang Q, Zhang J, et al. · ACS omega · 2020
  4. An Indirect Competitive Enzyme-Linked Immunosorbent Assay for the Determination of Brigatinib and Gilteritinib Using a Specific Polyclonal Antibody
    Kataoka H, Saita T, Oka A, et al. · Biological & pharmaceutical bulletin · 2022 · 被引 1cited 1

合成路线文献Synthetic-route papers

  1. Design, synthesis and biological evaluation of selective inhibitors against the L858R/T790 M/C797S mutant EGFR kinase based on the scaffold of brigatinib
    Ding S, Ding H, Zhan Z, et al. · European journal of medicinal chemistry · 2026
  2. Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase
    Högnäsbacka AA, Poot AJ, Kooijman E, et al. · Journal of medicinal chemistry · 2023
  3. Design, synthesis and evaluation of the Brigatinib analogues as potent inhibitors against tertiary EGFR mutants (EGFRdel19/T790M/C797S and EGFRL858R/T790M/C797S)
    Fang H, Wu Y, Xiao Q, et al. · Bioorganic & medicinal chemistry letters · 2022

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

布格替尼 杂质谱研究要点Brigatinib — impurity profiling notes

下面这些是拿到 布格替尼 的 92 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 92 impurity entries for Brigatinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances